Consultant utilization rates: Percentage of billable hours directly impacts revenue per employee and margin expansion
Large litigation cycles: Major product recalls, mass tort cases, or regulatory enforcement actions (automotive defects, medical device failures, construction disasters) drive episodic demand spikes
Corporate capital spending on risk management: Proactive consulting revenue correlates with manufacturing sector health and regulatory compliance budgets
Hiring and retention of senior technical staff: Ability to attract PhD-level talent in specialized fields determines capacity for revenue growth
moderate - Reactive consulting (litigation-driven) is relatively recession-resistant as product failures and legal disputes occur regardless of economic conditions. However, proactive consulting tied to new product development and manufacturing capex exhibits cyclical sensitivity. Industrial production and manufacturing activity correlate with corporate spending on design review and compliance services. Consumer spending indirectly affects product liability exposure through sales volumes.
Rising interest rates have modest negative impact through two channels: (1) higher discount rates compress valuation multiples for high-quality growth stocks, and (2) potential reduction in corporate capital spending on discretionary consulting services as financing costs increase. However, the non-discretionary nature of litigation-related work provides downside protection. The company's minimal debt ($0.21 D/E) eliminates direct financing cost sensitivity.
Tort reform and litigation trends: Legislative changes reducing product liability exposure or capping damages could structurally reduce demand for expert witness and failure analysis services
Regulatory environment shifts: Reduced enforcement activity or deregulation in key sectors (automotive safety, medical devices, environmental) could diminish compliance consulting demand
Technology disruption in forensic analysis: Advanced simulation software and AI-driven failure prediction could commoditize certain technical analysis services over time
quality growth - Investors are attracted to the asset-light, high-ROIC business model (25.5% ROE), strong free cash flow generation, and defensive characteristics from litigation-driven revenue. The stock appeals to those seeking exposure to specialized human capital businesses with pricing power and low capital intensity. However, modest revenue growth (4.2% TTM) and recent earnings contraction (-2.7%) have pressured the premium valuation (5.9x P/S), creating potential value opportunity if growth reaccelerates.
No analyst coverage available for this stock.
Trend
-4.7% vs SMA 50 · -7.4% vs SMA 200
Momentum
Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
EXPO News
Unable to load news
About
exponent is an engineering and scientific consulting firm providing solutions to complex problems. whether the firm investigates an incident that happened in the past, or assists with the development of a new product or service, exponent offers knowledge to assist its clients make informed, intelligent decisions. exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and business today. the firm's consultants analyze failures and accidents to determine their causes and provide answers to help prevent such problems. in addition, exponent evaluates human health and environmental concerns to find cost-effective solutions. exponent’s staff of approximately 900, located in 20 offices throughout the nation and 6 international offices, combines unparalleled technical expertise with the ability, when necessary, to focus this knowledge in extreme
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
EXPO◀ | $65.28 | -2.41% | $3.2B | 29.8 | +420.8% | 1821.4% | 1500 |
| $889.67 | -0.05% | $414.0B | 43.8 | +429.0% | 1312.8% | 1522 | |
| $286.51 | -1.18% | $299.4B | 34.3 | +1848.2% | 1898.2% | 1488 | |
| $173.99 | -1.18% | $234.3B | 32.3 | +974.1% | 759.8% | 1486 | |
| $227.38 | -0.72% | $179.2B | 82.1 | +3449.4% | 249.7% | 1504 | |
| $425.55 | -1.72% | $165.1B | 40.4 | +1033.0% | 1489.7% | 1506 | |
| $266.32 | -1.17% | $158.1B | 21.9 | +107.2% | 2912.3% | 1505 | |
| Sector avg | — | -1.20% | — | 40.7 | +1180.3% | 1492.0% | 1502 |